Minister for Finance and Revenue, Hammad Azhar says despite challenges, economy of the country is in much better condition than it was back in 2018 when the incumbent government assumed power.Talking in live call session along with Prime Minister, Imra...
Read More »Monthly Archives: April 2021
2nd ODI: Pakistan to face South Africa on Sunday
The second One Day International of three match series between Pakistan and South Africa will be played at Johannesburg tomorrow (Sunday).Match will start at 1:00 pm Pakistan Standard Time.Pakistan lead the three match series by one-nil.Source: Radio P...
Read More »Punjab Governor hails Federal Govt’s decision not to import Cotton from India
Punjab Governor Chaudhry Muhammad Sarwar has hailed Federal Government's decision not to import Cotton from India.He was chairing meeting of Agricultural Committee at Governor's House Lahore today (Saturday).The Committee recommended Federal government...
Read More »Govt takes number of initiatives under Ehsaas Program to turn Pakistan into welfare state
The government has taken a number of initiatives under the umbrella of Ehsaas Program for poverty alleviation and turn Pakistan into a welfare state.Ehsaas Program is providing relief to needy irrespective of political, religious and social divisions.U...
Read More »KP Govt to set up water testing laboratories in six divisional headquarters
Khyber Pakhtunkhwa government has decided to set up water testing laboratories in six divisional headquarters of the province.According to local government department, these laboratories will be established in Kohat, Bannu, D.I. Khan, Mardan, Swat and ...
Read More »یو ایس ایف ڈی اے نے جیمن کیئر کو نیوٹرلائزنگ اینٹی باڈی JMB2002 کے کلینیکل ٹرائل کے آغاز کی منظوری دے دی ہے
شنگھائی، 2 اپریل 2021/ ژن ہوا- ایشیا نیٹ/– 31 مارچ 2021 کو جیمن کیئر گروپ نے اعلان کیا کہ ان کے اینٹی- سارس- کوو-2 اینٹی باڈی JMB2002کو جسےجیمن کیئر شنگھائی ریسرچ سینٹر نے آزادانہ طور پر تیار کیاتھا، ایف ڈی اے نے امریکہ میں کلینیکل ٹرائل کے لئے منظوری دے دی ہے۔ پری کلینیکل اعداد […]
Read More »US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002
SHANGHAI, Apr. 2, 2021 /Xinhua-AsiaNet/–On March 31, 2021, Jemincare group announced that their anti-SARS-CoV-2 neutralizing antibody, JMB2002, independently developed by Jemincare Shanghai Research Center, was approved by FDA for clinical trial in the United States. Preclinical data showed that JMB2002 can precisely occupy the key epitope of the receptor binding domain (RBD) on the S1 […]
Read More »